Development of cardiovascular quality indicators for rheumatoid arthritis: Results from an international expert panel using a novel online process

Journal of Rheumatology

Volumn 42, Issue 9, 2015, Pages 1548-1555

  Barber, Claire E H ^a   Marshall, Deborah A ^b   Alvarez, Nanette ^b   John Mancini, G B ^b   Lacaille, Diane ^a   Keeling, Stephanie ^c   Antonio Avina Zubieta J ^a   Khodyakov, Dmitry ^d   Barnabe, Cheryl ^b   Faris, Peter ^b   Smith, Alexa ^e   Noormohamed, Raheem ^f   Hazlewood, Glen ^b   Martin, Liam O ^b   Esdaile, John M ^a,g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d RAND CORPORATION   (United States)

^e DALHOUSIE UNIVERSITY   (Canada)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

Author keywords

Cardiovascular diseases; Healthcare quality indicators; Primary prevention; Rheumatoid arthritis

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; EXERCISE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERPERSONAL COMMUNICATION; LIFESTYLE MODIFICATION; LIPID ANALYSIS; NUTRITIONAL COUNSELING; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING; SMOKING; SMOKING CESSATION PROGRAM; SYSTEMATIC REVIEW; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; COMPLICATION; CONSENSUS; EVIDENCE BASED MEDICINE; INTERNET;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CONSENSUS; EVIDENCE-BASED MEDICINE; HUMANS; INTERNET; QUALITY INDICATORS, HEALTH CARE; RISK ASSESSMENT;

EID: 84940706778     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.141603     Document Type: Article

References (33)

1. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-7.
2. Full LE, Monaco C. Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis. Cardiovasc Ther 2011;29:231-42.
3. Bergstrom U, Jacobsson LT, Turesson C. Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden. Rheumatology 2009;48:1600-5.
4. Radovits BJ, Fransen J, Al Shamma S, Eijsbouts AM, van Riel PL, Laan RF. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis. Arthritis Care Res 2010; 62:362-70.
5. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007;56:3583-7.
6. Desai SS, Myles JD, Kaplan MJ. Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Res Ther 2012;14:R270.
7. Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 2014;73:62-8.
8. Gossec L, Salejan F, Nataf H, Nguyen M, Gaud-Listrat V, Hudry C, et al. Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. Arthritis Care Res 2013;65:712-7.
9. Keeling SO, Teo M, Fung D. Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center. Clin Rheumatol 2011;30:1311-7.
10. Toms TE, Panoulas VF, Douglas KM, Griffiths H, Sattar N, Smith J P, et al. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis 2010; 69:683-8.
11. Scott IC, Ibrahim F, Johnson D, Scott DL, Kingsley GH. Current limitations in the management of cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol 2012;30:228-32.
12. Bartels CM, Kind AJ, Everett C, Mell M, McBride P, Smith M. Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis. Arthritis Rheum 2011;63:1221-30.
13. Bartels CM, Johnson H, Voelker K, Thorpe C, McBride P, Jacobs EA, et al. Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care. Arthritis Care Res 2014;66:1281-8.
14. Protogerou AD, Panagiotakos DB, Zampeli E, Argyris AA, Arida K, Konstantonis GD, et al. Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white coat" phenomenon. Arthritis Res Ther 2013;15:R142.
15. Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology 2007;46:1477-82.
16. McGlynn EA, Asch SM. Developing a clinical performance measure. Am J Prev Med 1998;14:14-21.
17. Kotter T, Blozik E, Scherer M. Methods for the guideline-based development of quality indicators-a systematic review. Implement Sci 2012;7:21.
18. MacLean CH, Saag KG, Solomon DH, Morton SC, Sampsel S, Klippel JH. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum 2004;51:193-202.
19. Khanna D, Arnold EL, Pencharz JN, Grossman JM, Traina SB, Lal A, et al. Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis. Semin Arthritis Rheum 2006;35:211-37.
20. Strombeck B, Petersson IF, Vliet Vlieland TP, EUMUSC.net WP6 group. Health care quality indicators on the management of rheumatoid arthritis and osteoarthritis: a literature review. Rheumatology 2013;52:382-90.
21. Barber CE, Smith A, Esdaile JM, Barnabe C, Martin LO, Faris P, et al. Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators. Arthritis Care Res 2015;67:169-79.
22. Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ 2003;326:816-9.
23. Dalal S, Khodyakov D, Srinivasan R, Straus S, Adams J. ExpertLens: A system for eliciting opinions from a large pool of non-collocated experts with diverse knowledge. Technol Forecast Soc 2011;78:1426-44.
24. Khodyakov D, Hempel S, Rubenstein L, Shekelle P, Foy R, Salem-Schatz S, et al. Conducting online expert panels: a feasibility and experimental replicability study. BMC Med Res Methodol 2011;11:174.
25. Rubenstein L, Khodyakov D, Hempel S, Danz M, Salem-Schatz S, Foy R, et al. How can we recognize continuous quality improvement? Int J Qual Health Care 2014;26:6-15.
26. Claassen CA, Pearson JL, Khodyakov D, Satow PM, Gebbia R, Berman AL, et al. Reducing the burden of suicide in the U.S.: the aspirational research goals of the National Action Alliance for Suicide Prevention Research Prioritization Task Force. Am J Prev Med 2014;47:309-14.
27. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, et al. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum 2009;61:370-7.
28. Mangione-Smith R, DeCristofaro AH, Setodji CM, Keesey J, Klein DJ, Adams JL, et al. The quality of ambulatory care delivered to children in the United States. N Engl J Med 2007;357:1515-23.
29. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA appropriateness method user's manual. Santa Monica, CA: RAND Corporation; 2001.
30. US Department of Health and Human Services (HHS) Public Reporting of Quality and Efficiency Measures Workgroup. Prioritizing the public in HHS public reporting: using and improving information on quality, cost, and coverage to support health care improvement. 2013. [Internet. Accessed May 29, 2015.] Available from: www.ahrq.gov/workingforquality/reports/hhsreporting.pdf
31. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006;333:417.
32. Coulter I, Adams A, Shekelle P. Impact of varying panel membership on ratings of appropriateness in consensus panels: a comparison of a multi-and single disciplinary panel. Health Serv Res 1995;30:577-91.
33. Campbell SM, Kontopantelis E, Hannon K, Burke M, Barber A, Lester HE. Framework and indicator testing protocol for developing and piloting quality indicators for the UK quality and outcomes framework. BMC Fam Pract 2011;12:85.